These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736 [TBL] [Abstract][Full Text] [Related]
4. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study. Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507 [TBL] [Abstract][Full Text] [Related]
7. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Reaume KT; Regal RE; Dorsch MP Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394 [TBL] [Abstract][Full Text] [Related]
8. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
9. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelets and stroke outcomes: state of the science. Meyer D Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767 [TBL] [Abstract][Full Text] [Related]
12. Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist. Fisher M Arch Neurol; 2006 Jan; 63(1):20-4. PubMed ID: 16401733 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet agents and randomized trials. Diener HC Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669 [TBL] [Abstract][Full Text] [Related]
15. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks. Hankey GJ; Eikelboom JW Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331 [TBL] [Abstract][Full Text] [Related]
16. Evolving perspectives on clopidogrel in the treatment of ischemic stroke. Gorelick P; Sechenova O; Hennekens CH J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470 [TBL] [Abstract][Full Text] [Related]
17. The approach to optimizing stroke care. Panagos PD Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet drugs in secondary prevention of stroke. Diener HC Int J Clin Pract; 1998 Mar; 52(2):91-7. PubMed ID: 9624789 [TBL] [Abstract][Full Text] [Related]
19. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke. Cavendish JJ; Cramer SC; Graham GD Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485 [TBL] [Abstract][Full Text] [Related]
20. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Burke JP; Sander S; Shah H; Zarotsky V; Henk H Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]